Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies.
Enass H RaffaHelen M BransonBo NganSarah AlexanderOussama AblaPublished in: Cancer reports (Hoboken, N.J.) (2021)
Optimal treatment for children with relapsed ALCL involving the CNS remains unclear. Novel agents, including ALK inhibitors, that have CNS-penetration might be helpful and pediatric studies are warranted.
Keyphrases
- diffuse large b cell lymphoma
- blood brain barrier
- acute lymphoblastic leukemia
- young adults
- single cell
- acute myeloid leukemia
- mental health
- cell therapy
- multiple myeloma
- stem cells
- cerebrospinal fluid
- combination therapy
- human health
- free survival
- risk assessment
- climate change
- mesenchymal stem cells
- case control
- epidermal growth factor receptor